VIVUS, Inc. (VVUS): Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting
10/30/2009 9:15:04 AM
More...
|
Orexigen Therapeutics, Inc. (OREX) Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The The Obesity Society
10/27/2009 9:36:31 AM
More...
|
Data on VIVUS, Inc. (VVUS)'s Qnexa To Be Featured at The Obesity Society Annual Meeting
10/5/2009 8:10:21 AM
More...
|